Putting Science to Work

Archives / 2015 / September

  • Syngene share strength reflects India's contract research opportunity

    Times of India-15/09/2015 .Among the major India players, Syngene is the only pure CRO, and is estimated to have 40% of the market.

  • Syngene International Jumps 32% From Issue Price Within One Quarter

    CNBC TV18- 15/09/2015. "Syngene International is targeting a growth of USD 250 million by FY2018", says Peter Bains CEO of the company) .

  • CROs Are Making Headlines -India’s drug discovery service sector is heating up

    Contract Pharma-11/09/2015 .Syngene says it is intent on establishing new capabilities and augmenting existing services across the discovery & development continuum..

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

FB Side
Inactive